Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD19 antibody

The Mouse Monoclonal anti-CD19 antibody has been validated for FACS and IF. It is suitable to detect CD19 in samples from Human.
Catalog No. ABIN6936612

Quick Overview for CD19 antibody (ABIN6936612)

Target

See all CD19 Antibodies
CD19 (CD19 Molecule (CD19))

Reactivity

  • 342
  • 170
  • 47
  • 32
  • 19
  • 13
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 234
  • 128
  • 64
  • 6
  • 4
  • 4
  • 2
Mouse

Clonality

  • 319
  • 112
  • 6
Monoclonal

Conjugate

  • 134
  • 26
  • 25
  • 24
  • 21
  • 11
  • 9
  • 8
  • 8
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This CD19 antibody is un-conjugated

Application

  • 339
  • 119
  • 78
  • 65
  • 65
  • 63
  • 29
  • 20
  • 20
  • 14
  • 14
  • 11
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

CVID3-155
  • Specificity

    CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.

    Cross-Reactivity (Details)

    Human and Monkey.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human CD19 protein

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: hPBL or Raji cells. Human tonsil, lymph node or spleen.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    CD19 (CD19 Molecule (CD19))

    Alternative Name

    CD19

    Background

    B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CVID3, Leu-12, Lymphocyte Surface Antigen, T-cell surface antigen Leu-12,CD19 (B-Lymphocyte Marker)
    Cellular localisation: Cell Surface

    Molecular Weight

    95kDa

    Gene ID

    930, 652262

    UniProt

    P15391

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!